Jonathan C. Trent, Andrew J. Wagner, Steven Attia, Mark Agulnik, Breelyn A. Wilky, William D. Tap, Margaret von Mehren, Elizabeth J. Davis, Liangxing Zou, Nisha Shah, Kevin Moynihan, Julia Lawrence, Lei Sun, Neeta Somaiah. "Peak part 1 summary: A phase 3, randomized, open-label, multicenter clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.826